Comparative Pharmacology
Head-to-head clinical analysis: DEXTROSE 20 IN PLASTIC CONTAINER versus DEXTROSE 4 IN MODIFIED LACTATED RINGER S IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DEXTROSE 20 IN PLASTIC CONTAINER versus DEXTROSE 4 IN MODIFIED LACTATED RINGER S IN PLASTIC CONTAINER.
DEXTROSE 20% IN PLASTIC CONTAINER vs DEXTROSE 4% IN MODIFIED LACTATED RINGER'S IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dextrose is a monosaccharide that serves as a source of calories and water for parenteral nutrition. It is oxidized to carbon dioxide and water, providing energy. Administration of hypertonic dextrose solutions increases blood glucose levels, which can stimulate insulin secretion and promote cellular glucose uptake.
Dextrose provides glucose for cellular energy metabolism. Lactated Ringer's solution replaces extracellular fluid and electrolytes. Lactate is metabolized to bicarbonate in the liver, providing buffering capacity for metabolic acidosis.
Intravenous infusion; adult dose: 500-1000 mL of 20% dextrose solution (100-200 g dextrose) administered over 1-2 hours; maximum infusion rate: 0.5 g/kg/hour. Frequency: as needed for hypoglycemia or as part of parenteral nutrition.
Intravenous infusion; adult dose is 500-1000 mL per 24 hours, titrated to fluid and electrolyte needs.
None Documented
None Documented
Plasma half-life is approximately 2-5 minutes under normal conditions due to rapid cellular uptake and metabolism; prolonged in hyperglycemic states or renal impairment.
2–4 hours (intravenous). Clinical context: reflects glucose clearance; prolonged in renal impairment.
Dextrose is completely metabolized to carbon dioxide and water via glycolysis and the citric acid cycle; negligible renal excretion of unchanged drug. <1% excreted unchanged in urine.
Renal: >99% as glucose. Biliary/fecal: negligible (<1%).
Category C
Category C
IV Fluid
IV Fluid